Matches in Nanopublications for { ?s ?p "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP103814.RAPp2dMen3Ri8CX9EzAUVqfSDCocZorv1i3Gs46a1EMfc130_assertion description "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103814.RAPp2dMen3Ri8CX9EzAUVqfSDCocZorv1i3Gs46a1EMfc130_provenance.
- NP233766.RA3uIuRpoOw_Olf_2T3XPvYHned05sIvDACDXE0u8_8tU130_assertion description "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233766.RA3uIuRpoOw_Olf_2T3XPvYHned05sIvDACDXE0u8_8tU130_provenance.